Sofia, Bulgaria November 20, 2024 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for October 2024 the Company recorded a decrease in sales of 8% compared to the same month of the previous year, incl. 2% decrease in domestic sales and 10% decrease in export sales.

For the period from the beginning of 2024, the Company recorded a decrease in sales of 8%, incl. 4% increase of domestic sales and 14% decrease in export sales.